WASHINGTON, June 1, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participateat the following upcoming investor conferences in June 2018:
The Jefferies 2018 Global Healthcare Conference in New York City on Tuesday, June 5, 2018.
The JMP Securities Life Sciences Conference in New York City on Wednesday, June 20, 2018. A panel discussion is scheduled for 11:30 a.m. Eastern Time.
The corporate presentation given at both the Jefferies Healthcare Conference and JMP Life Sciences Conference will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) email@example.com
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-june-2018-investor-conferences-300658201.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All